OneSource Specialty Pharma Limited (NSE: ONESOURCE) receives USFDA EIR with VAI classification for its Bengaluru facility, marking successful completion of i.
Onesource Specialty Pharma Limited (NSE: ONESOURCE) announces Q2FY27 results with revenue up 37% YoY and EBITDA up 53% YoY.
Onesource Specialty Pharma Limited (NSE: ONESOURCE) stock price falls 5% intraday to ₹1538.5. The trendline status has shifted to breakdown, indicating a fre.
OneSource Specialty Pharma Limited (NSE: ONESOURCE) announced strong Q4 FY26 results with revenue up 47% QoQ and EBITDA expanding more than 5x.